Literature DB >> 24858687

The Fe-heme structure of met-indoleamine 2,3-dioxygenase-2 determined by X-ray absorption fine structure.

Jade B Aitken1, Christopher J D Austin2, Nicholas H Hunt3, Helen J Ball3, Peter A Lay4.   

Abstract

Multiple-scattering (MS) analysis of EXAFS data on met-indoleamine 2,3-dioxygenase-2 (IDO2) and analysis of XANES have provided the first direct structural information about the axial donor ligands of the iron center for this recently discovered protein. At 10K, it exists in a low-spin bis(His) form with Fe-Np(av)=1.97Å, the Fe-NIm bond lengths of 2.11Å and 2.05Å, which is in equilibrium with a high-spin form at room temperature. The bond distances in the low-spin form are consistent with other low-spin hemeproteins, as is the XANES spectrum, which is closer to that of the low-spin met-Lb than that of the high-spin met-Mb. The potential physiological role of this spin equilibrium is discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EXAFS; Heme environment; Indoleamine 2,3-dioxygenase-2 (IDO2); Mixed-spin species; X-ray absorption fine structure

Mesh:

Substances:

Year:  2014        PMID: 24858687     DOI: 10.1016/j.bbrc.2014.05.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Xiu-Xiu Wang; Si-Yu Sun; Qing-Qing Dong; Xiao-Xiang Wu; Wei Tang; Ya-Qun Xing
Journal:  Medchemcomm       Date:  2019-08-15       Impact factor: 3.597

Review 2.  A short history of heme dioxygenases: rise, fall and rise again.

Authors:  Emma L Raven
Journal:  J Biol Inorg Chem       Date:  2016-12-01       Impact factor: 3.358

Review 3.  An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase-Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

Authors:  Li Bo; Tan Guojun; Guo Li
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.